Advancing Precision Therapy for Urologic Tumors: Integrating Immunotherapy and Organoid Models

About this Research Topic

Submission deadlines

  1. Manuscript Summary Submission Deadline 17 February 2026 | Manuscript Submission Deadline 7 June 2026

  2. This Research Topic is currently accepting articles.

Background

Urologic oncology has seen significant advances in precision therapy, with immunotherapy and organoid-based approaches at the forefront. Immunotherapy offers transformative potential for improving patient outcomes, driving research into novel agents and combination regimens. Concurrently, organoids can recapitulate the characteristics of the original tumors, allowing for personalized drug testing and the prediction of treatment responses. They have opened new avenues for personalized medicine, enabling more accurate drug screening and treatment planning. Using immune co-culture technology, breakthroughs have been achieved in the immunotherapy of tumors. Despite these exciting advancements, many aspects of immunotherapy and organoid-based precision medicine in urologic tumors remain unclear. The complex interplay between the immune system and tumors, as well as the challenges in translating organoid-based research into clinical practice, warrants further exploration.



This Research Topic aims to address critical barriers in urologic tumor precision therapy: (1) suboptimal efficacy and immune resistance in immunotherapy, (2) limited biomarkers for predicting response, and (3) challenges in standardizing and clinically translating organoid models.



Recent advances provide pathways forward:

• New Immunotherapies: Novel immunotherapeutic drugs and combination regimens targeting multiple immune checkpoints or combining with other therapies are being developed. These show potential in enhancing efficacy and reducing side effects.



• Immune sensitivity/resistance: The tumor microenvironment has emerged as a key regulator. Strategies to block immunosuppressive molecules or leverage new biomarkers (e.g., cytokine profiles) are being developed to overcome resistance and boost sensitivity.



• Organoid refinement: Improved techniques enable better tumor recapitulation. Co-culturing organoids with immune cells helps simulate the in vivo environment, thereby facilitating the development of more effective immunotherapies.



• Genetic-driven precision therapy: Advances in genetic profiling have accelerated targeted treatment development. PARP inhibitors have demonstrated remarkable efficacy in urologic tumors harboring HRR (Homologous Recombination Repair) gene mutations, offering a novel therapeutic option for patients with limited conventional treatment responses. Meanwhile, belzutifan has emerged as a breakthrough agent for VHL (von Hippel-Lindau) disease-associated tumors and pheochromocytoma, targeting the underlying genetic aberrations to inhibit tumor growth and progression. These gene-based strategies highlight the potential of molecular subtyping in guiding personalized treatment decisions.



We welcome submissions of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Systematic Review, Technology and Code.

Submission topics include:

• Develop and evaluate new immunotherapeutic drugs and regimens for urologic tumors using genomics



• Study the genetic and molecular determinants of immune sensitivity in urologic tumors, focusing on how genomic variants and gene-expression programs in tumor-associated immune cells and cytokine networks influence responsiveness.



• In-depth research on immune resistance in urologic tumors, including the identification of resistance-related genes and pathways, and potential strategies to overcome resistance.



• Apply organoid-based precision oncology to urologic tumors by integrating genomic and transcriptomic profiling to establish models, screen potential drugs and immunotherapies, and generate actionable diagnostic and prognostic insights.



• Genetic mechanism research of urologic tumors, focusing on HRR gene mutations, VHL gene abnormalities, and other key genetic alterations related to tumorigenesis and progression.



• Clinical and preclinical studies on targeted therapies for genetically driven urologic tumors, such as PARP inhibitors and belzutifan.



• Development and validation of genetic biomarkers for predicting treatment response and prognosis in urologic tumors.



This Topic seeks contributions that leverage these advances to deepen mechanistic understanding, identify robust biomarkers, standardize organoid methodologies, and translate findings into clinical practice—ultimately enhancing the precision, efficacy, and durability of treatment for urologic cancers.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Data Report
  • Editorial
  • FAIR² Data
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Urologic tumors, Immunotherapy, Organoids, Immune sensitivity, Immune resistance, Precision medicine, Tumor microenvironment, Personalized treatment

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.